The risks of PPI therapy
- 14 February 2012
- journal article
- review article
- Published by Springer Nature in Nature Reviews Gastroenterology & Hepatology
- Vol. 9 (3), 132-139
- https://doi.org/10.1038/nrgastro.2011.272
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International StudiesThe American Journal of Medicine, 2011
- Do proton pump inhibitors decrease calcium absorption?Journal of Bone and Mineral Research, 2010
- Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk PatientsGastroenterology, 2010
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor CoadministrationJournal of the American College of Cardiology, 2010
- Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control studyOsteoporosis International, 2010
- Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: A randomized, crossover, controlled clinical trialJournal of Bone and Mineral Research, 2010
- Acid-Suppressive Medication Use and the Risk for Hospital-Acquired PneumoniaJAMA, 2009
- Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older AdultsCalcified Tissue International, 2008
- Use of Proton Pump Inhibitors and the Risk of Community-Acquired PneumoniaArchives of Internal Medicine, 2007
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004